Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
NCT07249827

A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guided Infraclavicular Block

Led by McGill University Health Centre/Research Institute of the McGill University Health Centre · Updated on 2026-01-07

69

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will compare three different doses of perineural dexmedetomidine 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg as adjuvants to local anesthetics for ultrasound-guided infraclavicular brachial plexus blocks (ICBs). Our research hypothesis is that 1.33 mcg/kg will provide a 15%-longer duration than 1mcg/kg, which in turn will provide a 15%-longer duration than 0.67 mcg/kg. Since analgesic duration and sensory duration can be influenced by intake of pain medications and surgical trauma to small cutaneous nerves, respectively, we will select motor block duration as the main outcome to better target the action of dexmedetomidine on the brachial plexus.

CONDITIONS

Official Title

A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guided Infraclavicular Block

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients undergoing upper limb surgery at or below the elbow
  • Age between 18 and 75 years
  • American Society of Anesthesiologists classification 1-3
  • Body mass index between 18 and 35 kg/m2
Not Eligible

You will not qualify if you...

  • Adults unable to give their own consent
  • Allergy or contraindication to dexmedetomidine
  • Exposure to dexmedetomidine in the previous 48 hours
  • Pre-existing neuropathy
  • Coagulopathy or blood clotting disorders
  • Renal failure
  • Hepatic failure
  • Allergy to local anesthetics
  • Pregnancy
  • Breastfeeding
  • Prior surgery in the infraclavicular region
  • Chronic pain requiring opioid use at home

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

McGill University Health Centre

Montreal, Quebec, Canada, H3G 1A4

Actively Recruiting

Loading map...

Research Team

J

Julián Aliste, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here